Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms
Bacterial multiresistance to drugs is a rapidly growing global phenomenon. New resistance mechanisms have been described in different bacterial pathogens, threatening the effective treatment of even common infectious diseases. The problem worsens in infections associated with biofilms because, in ad...
Main Authors: | Agostinho Alves de Lima e Silva, André Rio-Tinto |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2024-01-01
|
Series: | Interdisciplinary Perspectives on Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2024/9109041 |
Similar Items
-
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens.
by: Shankar Thangamani, et al.
Published: (2015-01-01) -
Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).
by: Ahmed AbdelKhalek, et al.
Published: (2018-01-01) -
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
by: Denise Rossato Silva, et al. -
Synergistic antibacterial effect of silver and ebselen against multidrug‐resistant Gram‐negative bacterial infections
by: Lili Zou, et al.
Published: (2017-08-01) -
Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
by: Holly C. May, et al.
Published: (2018-03-01)